Role of 18F-FDG PET/CT in the management of head and neck cancer patients with persistent cervical lymphadenopathy following chemoradiation.
Anu SharmaHumzah QuereshyClaudia I CabreraNicole FowlerShawn LiJennifer DorthJason E ThuenerRod P RezaeeAkina TamakiPublished in: Head & neck (2024)
PPV and NPV of PET/CT for detecting residual neck disease in patients with post-treatment LAD was lower than those of HNSCC patients with and without persistent LAD reported in other studies.